Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide.
The results reported in this paper show the changes in chromatin structure caused by the binding of adriamycin (ADR), daunorubicin (DR) and ethidium bromide (EtdBr) to DNA in chromatin, either isolated or in nuclei or whole cells. Micrococcal nuclease was used as the structural probe of chromatin. The binding of the drugs to chromatin DNA induced two structural changes. First, it produced an unfolding of the overall chromatin structure as evidenced by the increased production of acid-soluble oligonucleotides for the drug-treated samples above the level of the control sample. Second, it caused a disruption of the core particle structure with increased production of DNA of subnucleosomal size and smearing of the nucleosome pattern. The effects were greatest for duanorubicin, followed by adriamycin and ethidium bromide.
D001482:Base Composition; D002467:Cell Nucleus / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002843:Chromatin / Q000378:metabolism*; D004247:DNA / Q000378:metabolism*; D003630:Daunorubicin / Q000378:metabolism*; D004317:Doxorubicin / Q000378:metabolism*; D004996:Ethidium / Q000378:metabolism*; D006367:HeLa Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D007364:Intercalating Agents / Q000378:metabolism; D008836:Micrococcal Nuclease
D002843:Chromatin; D007364:Intercalating Agents; D004317:Doxorubicin; D004247:DNA; D008836:Micrococcal Nuclease; D004996:Ethidium; D003630:Daunorubicin